{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:40:53Z","timestamp":1773283253039,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2015,7,7]],"date-time":"2015-07-07T00:00:00Z","timestamp":1436227200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1007\/s11255-015-1048-3","type":"journal-article","created":{"date-parts":[[2015,7,6]],"date-time":"2015-07-06T10:33:16Z","timestamp":1436178796000},"page":"1509-1514","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Oncological outcomes of a single but extensive transurethral resection followed by appropriate intra-vesical instillation therapy for newly diagnosed non-muscle-invasive bladder cancer"],"prefix":"10.1007","volume":"47","author":[{"given":"Takuya","family":"Koie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chikara","family":"Ohyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shogo","family":"Hosogoe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayato","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Imai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shingo","family":"Hatakeyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Yoneyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tohru","family":"Yoneyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Tobisawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuyuki","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,7,7]]},"reference":[{"key":"1048_CR1","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3109\/21681805.2013.769461","volume":"47","author":"S Holm\u00e4mg","year":"2013","unstructured":"Holm\u00e4mg S (2013) High-grade non-muscle-invasive bladder cancer: is re-resection necessary in all patients before intravesical bacillus Calmette\u2013Gu\u00e9rin treatment? Scand J Urol 47:363\u2013369","journal-title":"Scand J Urol"},{"key":"1048_CR2","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/01.ju.0000070437.14275.e0","volume":"170","author":"M Grimm","year":"2003","unstructured":"Grimm M, Steinhoff C, Simon X et al (2003) Effect of routine repeat transurethral resection for superficial bladder cancer: a long-term observational study. J Urol 170:433\u2013437","journal-title":"J Urol"},{"key":"1048_CR3","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/00005392-199707000-00017","volume":"158","author":"MS Cookson","year":"1997","unstructured":"Cookson MS, Herr HW, Zhang ZF et al (1997) The treated natural history of high risk superficial bladder cancer: 15-year outcome. J Urol 158:62\u201367","journal-title":"J Urol"},{"key":"1048_CR4","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.eururo.2011.03.017","volume":"59","author":"M Babjuk","year":"2011","unstructured":"Babjuk M, Oosterlinck W, Sylvester R et al (2011) European Association of Urology (EAU): EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update. Eur Urol 59:997\u20131008","journal-title":"Eur Urol"},{"key":"1048_CR5","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.juro.2006.08.070","volume":"177","author":"HW Herr","year":"2007","unstructured":"Herr HW, Donat SM, Dalbagni G et al (2007) Can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy? J Urol 177:75\u201379","journal-title":"J Urol"},{"key":"1048_CR6","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.eururo.2010.04.019","volume":"58","author":"M Babjuk","year":"2010","unstructured":"Babjuk M (2010) Second resection for non-muscle-invasive bladder carcinoma: current role and future perspectives. Eur Urol 58:191\u2013192","journal-title":"Eur Urol"},{"key":"1048_CR7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.eururo.2007.08.015","volume":"53","author":"JA Witjes","year":"2008","unstructured":"Witjes JA, Hendricksen K (2008) Intravesical pharmacotherapy for non-muscle-invasive bladder cancer: a critical analysis of currently available drugs, treatment schedules, and long-term results. Eur Urol 53:45\u201352","journal-title":"Eur Urol"},{"key":"1048_CR8","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0022-5347(17)36724-1","volume":"148","author":"MS Cookson","year":"1992","unstructured":"Cookson MS, Sarosdy MF (1992) Management of stage T1 superficial bladder cancer with intravesical bacillus Calmette\u2013Gu\u00e9rin therapy. J Urol 148:797\u2013801","journal-title":"J Urol"},{"key":"1048_CR9","first-page":"497","volume-title":"AJCC cancer staging manual","author":"Urinary Bladder","year":"2010","unstructured":"Bladder Urinary (2010) In: Edge SB, Byrd DR, Compton CC et al (eds) AJCC cancer staging manual, 7th edn. Springer, New York, pp 497\u2013505","edition":"7"},{"key":"1048_CR10","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","volume":"49","author":"RJ Sylvester","year":"2006","unstructured":"Sylvester RJ, van der Meijden APM, Oosterlinck W et al (2006) Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 49:466\u2013477","journal-title":"Eur Urol"},{"key":"1048_CR11","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.urology.2007.11.080","volume":"71","author":"T Yoneyama","year":"2008","unstructured":"Yoneyama T, Ohyama C, Imai A et al (2008) Low-dose instillation therapy with bacillice Calmette\u2013Gu\u00e9rin Tokyo 172 strain after transurethral resection: his torical cohort study. Urology 71:1161\u20131165","journal-title":"Urology"},{"key":"1048_CR12","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.eururo.2009.08.024","volume":"57","author":"GS Kulkarni","year":"2010","unstructured":"Kulkarni GS, Hakenberg OW, Gschwend JE et al (2010) An updated critical analysis of the treatment strategy for newly diagnosed high-grade T1 (previously T1G3) bladder cancer. Eur Urol 57:60\u201370","journal-title":"Eur Urol"},{"key":"1048_CR13","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1100\/tsw.2011.29","volume":"11","author":"HW Herr","year":"2011","unstructured":"Herr HW (2011) Role of re-resection in non-muscle-invasive bladder cancer. Sci World J 11:283\u2013288","journal-title":"Sci World J"},{"key":"1048_CR14","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.eururo.2010.03.007","volume":"58","author":"RT Divrik","year":"2010","unstructured":"Divrik RT, Sahin AF, Yildirim U et al (2010) Impact of routine second transurethral resection on the long-term outcome of patients with newly diagnosed pT1 urothelial carcinoma with respect to recurrence, progression rate, and disease-specific survival: a prospective randomized clinical trial. Eur Urol 58:185\u2013190","journal-title":"Eur Urol"},{"key":"1048_CR15","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0302-2838(02)00068-4","volume":"41","author":"M Brausi","year":"2002","unstructured":"Brausi M, Collette L, Kurth K et al (2002) Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies. Eur Urol 41:523\u2013531","journal-title":"Eur Urol"},{"key":"1048_CR16","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000075961","volume":"72","author":"MA Zurkirchen","year":"2004","unstructured":"Zurkirchen MA, Sulser T, Gaspert A et al (2004) Second TUR of superficialtransitional cell carcinoma of the bladder: a must even for experienced urologist. Urol Int 72:99\u2013102","journal-title":"Urol Int"},{"key":"1048_CR17","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1111\/j.1464-410X.2011.10638.x","volume":"109","author":"H Mostafid","year":"2012","unstructured":"Mostafid H, Brausi M (2012) Measuring and improving the quality of transurethral resection for bladder tumour (TURBT). BJU Int 109:1579\u20131582","journal-title":"BJU Int"},{"key":"1048_CR18","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/1097-0142(19950115)75:2<552::AID-CNCR2820750219>3.0.CO;2-H","volume":"75","author":"H Akaza","year":"1995","unstructured":"Akaza H, Hinotsu S, Aso Y et al (1995) Bacillus Calmette\u2013Gu\u00e9rin treatment of existing papillary bladder cancer and carcinoma in situ of the bladder. Cancer 75:552\u2013559","journal-title":"Cancer"},{"key":"1048_CR19","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1159\/000049828","volume":"40","author":"W Oosterlinck","year":"2001","unstructured":"Oosterlinck W, Bono AV, Mack D et al (2001) Frequency of positive biopsies after visual disappearance of superficial bladder cancer marker lesions. Eur Urol 40:515\u2013517","journal-title":"Eur Urol"},{"key":"1048_CR20","doi-asserted-by":"crossref","unstructured":"Shelley MD, Court JB, Kynaston H et al. (2000) Intravesical bacillus Calmette\u2013Gu\u00e9rin in Ta and T1 bladder cancer. Cochrane Database Syst Rev CD001986","DOI":"10.1002\/14651858.CD001986"},{"key":"1048_CR21","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/S0022-5347(05)64273-5","volume":"168","author":"RJ Sylvester","year":"2002","unstructured":"Sylvester RJ, van der MEIJDEN AP, Lamm DL (2002) Intravesical bacillus Calmette\u2013Gu\u00e9rin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials. J Urol 168:1964\u20131970","journal-title":"J Urol"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-015-1048-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-015-1048-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-015-1048-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T01:00:50Z","timestamp":1566954050000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-015-1048-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,7]]},"references-count":21,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["1048"],"URL":"https:\/\/doi.org\/10.1007\/s11255-015-1048-3","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,7]]}}}